Evolution of acquired resistance to anti-cancer therapy
- 1 August 2014
- journal article
- review article
- Published by Elsevier in Journal of Theoretical Biology
- Vol. 355, 10-20
Abstract
No abstract availableKeywords
This publication has 108 references indexed in Scilit:
- The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancersNature, 2012
- Evolutionary Modeling of Combination Treatment Strategies To Overcome Resistance to Tyrosine Kinase Inhibitors in Non-Small Cell Lung CancerMolecular Pharmaceutics, 2011
- Acquired Resistance to BRAF Inhibitors Mediated by a RAF Kinase Switch in Melanoma Can Be Overcome by Cotargeting MEK and IGF-1R/PI3KCancer Cell, 2010
- The Worst Drug Rule Revisited: Mathematical Modeling of Cyclic Cancer TreatmentsBulletin of Mathematical Biology, 2010
- A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell SubpopulationsCell, 2010
- Evolution of resistance to anti-cancer therapy during general dosing schedulesJournal of Theoretical Biology, 2010
- Cancer Cell Metabolism: Warburg and BeyondCell, 2008
- A generalized Luria–Delbrück modelMathematical Biosciences, 2005
- Dynamics of chronic myeloid leukaemiaNature, 2005
- Targeted cancer therapyNature, 2004